US stocks are mixed in afternoon trading; DuPont jumps
By KEN SWEET, Associated Press
Oct 6, 2015 1:31 PM CDT
FILE - This May 11, 2007, file photo, shows a Wall Street sign near the flag-draped facade of the New York Stock Exchange. Japan led world stock markets higher Tuesday, Oct. 6, 2015, on hopes for new stimulus from its central bank while investors were also buoyed by the prospect that the Federal Reserve...   (Associated Press)

NEW YORK (AP) — U.S. stock indexes are mixed in afternoon trading Tuesday, taking a pause after five straight days of gains. DuPont soared on news that its embattled CEO will retire, while biotechnology companies sank again. Energy stocks climbed as the price of crude oil rose sharply.

KEEPING SCORE: The Dow Jones industrial average rose 59 points, or 0.4 percent, to 16,834 as of 2:25 p.m. Eastern. The Standard & Poor's 500 index was down three points, or 0.2 percent, to 1,983 and the Nasdaq composite fell 28 points, or 0.6 percent, to 4,752.

DUPONT: The chemical giant DuPont rose $4.56, or 9 percent, to $55.85, the biggest gainer in the Dow average and the S&P 500. DuPont's CEO Ellen Kullman said she would retire next week. DuPont's profits have lagged in recent years and the company has been a target of activist investors like Nelsen Peltz.

SPINOFF: Mining and drilling company Freeport-McMoRan rose 52 cents, or 5 percent, to $11.71 after the company said it is exploring the idea of spinning off its oil and natural gas business into a separate company. Freeport is primarily a copper and gold mining company, but got into oil and gas drilling in recent years as oil prices were climbing. Activist investor Carl Icahn disclosed two months ago that he had bought an 8.5 percent stake in the company.

CENTRAL BANKERS: Markets are increasingly confident the Federal Reserve will hold off for longer on raising interest rates following last week's jobs report, which showed that the U.S. economy was creating fewer jobs. On Thursday, investors will get the minutes from the Fed's meeting in September, which should provide clues on whether policymakers still feel confident about raising interest rates.

UNHEALTHY: Biotechnology stocks were among the hardest hit on Tuesday. The Nasdaq Biotechnology Index sank 4 percent. Biotech stocks have been hammered in recent months because of investor concerns that the industry might face more scrutiny from Washington over its drug pricing practices. The index is down 24 percent from its peak in July.

ENERGY: U.S. benchmark crude jumped $1.97 to $48.24 a barrel on the New York Mercantile Exchange. That helped send oil and gas companies sharply higher. ConocoPhillips, Chevron and ExxonMobil rose between 2 and 4 percent each.

BONDS, CURRENCIES: U.S. government bond prices rose slightly. The yield on the 10-year Treasury note edged down to 2.05 percent. The dollar slipped to 120.36 yen and the euro rose to $1.1265.

METALS: In metals trading, the price of gold rose $8.80 to $1,146.40 an ounce, silver rose 28 cents to $15.98 an ounce and copper was little changed at $2.36 a pound.